DGE	Genes	Process~name	num_of_Genes	gene_group	percentage%	P-value	Benjamini and Hochberg (FDR)	 Hommel singlewise process	Bonferroni single-step process	Hommel singlewise process	Hochberg step-up process	Benjamini and Yekutieli
up	IGKV3D-20; IGKV1-12; C1R; IGKV1-39; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV2D-40; IGKV2D-28; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-51; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV6-57; IGHV1-69; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHG2; IGHG3; IGHG4; C1QA; C1QB; C1QC; C9; IGLV7-43; IGKV1-16; IGKV1D-39; IGKV3-11; CFI; IGKV2-30; IGKV4-1; IGKV5-2; IGHV4-34; C2; C1S; IGLC2; IGLC3; IGHV1-2; IGLV3-21; IGHV1-18; TRDC; IGHV4-4; IGHV3-21; IGHV5-51; IGHV3-20; IGHD; IGHV1-24; IGHV1-69-2; IGHV3-49; IGHV4-61; TRBC2; IGLL5; IGHV3-15; TRBC1; IGHV1OR15-9; IGHV6-1; IGHV3-74; IGHE; IGHV1-3; IGHV3-66; IGHV3-72; IGHA2; IGHV3-43; IGHV3-73;	GO:0006958~complement activation, classical pathway	83	161	51.5527950310559	0	0	0	0	0	0	0
down	TGM5; PPL; CSTA; KRT3; KRT13; SPRR2E; TGM1; DSG3; SPRR2B; SPRR2A; KRT2; KRT6C; KRT76; DSG1; DSC2; KRT32; KRT31; PRSS8; KRT24; KRT77; KRT78; SPINK5; PKP3;	GO:0070268~cornification	23	113	20.353982300885	0	0	0	0	0	0	0
down	NFASC; MAL; EPB41L3;	GO:0002175~protein localization to paranode region of axon	3	5	60	0.00010384564723242	0.00931149303517416	0.221087382957834	0.22347583284418	0.196820975200793	0.221087382957834	0.0768347244043303
down	RASAL1; PRKAA2; GPLD1; SYT17; SYT7; SYT8; CPNE4;	GO:0071277~cellular response to calcium ion	7	82	8.53658536585366	0.00013132782714697	0.0113046993608117	0.279465616168766	0.282617484020293	0.226934485309975	0.279465616168766	0.0932818675351704
down	PLA2G4B; PLA2G2A; TNFAIP8L3; PLA2G4F; PLA2G4D; GDPD3;	GO:0006644~phospholipid metabolic process	6	57	10.5263157894737	0.00013846284023866	0.011460462776677	0.294510461187635	0.297972032193601	0.234694514204533	0.294510461187635	0.0945671650792993
down	PLA2G4B; PLA2G2A; PLA2G4F; PLA2G4D;	GO:0036148~phosphatidylglycerol acyl-chain remodeling	4	18	22.2222222222222	0.00014789703054274	0.0117879411010364	0.314429086933872	0.318274409727983	0.244940941240333	0.314429086933872	0.0972693855186532
down	MAPT; PRKAA2; BEX4;	GO:1904428~negative regulation of tubulin deacetylation	3	6	50	0.000154318843542	0.0118605054036566	0.327927542526751	0.332094151302385	0.252002671504087	0.327927542526751	0.097868157184202
down	SRPX2; CSTA; DSG1; CNN3; ESAM; DSG3; PKP3; DSC2; DLG2;	GO:0098609~cell-cell adhesion	9	152	5.92105263157895	0.0002096677791179	0.0149544344546161	0.445334362846432	0.451205060661733	0.300210392561944	0.445334362846432	0.123398024957182
down	FUT3; SRCIN1; BEX4; CAMSAP3; RHOD; RND3; AMOTL2;	GO:0030334~regulation of cell migration	7	89	7.86516853932584	0.00021073828216455	0.0149544344546161	0.447397373035356	0.453508783218128	0.300934266930988	0.447397373035356	0.123398024957182
down	RHCG; RHBG; RHCE;	GO:0072488~ammonium transmembrane transport	3	7	42.8571428571429	0.00021840514699	0.0149544344546161	0.463455721912798	0.470007876322498	0.305985610933002	0.463455721912798	0.123398024957182
down	SDK2; SLITRK6; PCDHB16; FLRT3; PCDHB13; PCLO;	GO:0007416~synapse assembly	6	63	9.52380952380952	0.00022931985920182	0.0149544344546161	0.486158101507872	0.49349633700233	0.31322143131081	0.486158101507872	0.123398024957182
down	PLA2G4B; PLA2G2A; PLA2G4F; PLA2G4D;	GO:0036150~phosphatidylserine acyl-chain remodeling	4	21	19.047619047619	0.00024826581132875	0.0157137654699845	0.526075254205625	0.534268025979474	0.325228212840665	0.526075254205625	0.129663721454737
down	EDN2; ACADL; NMU; ARRDC3;	GO:0001659~temperature homeostasis	4	22	18.1818181818182	0.00029051263873858	0.0177848346889331	0.615305768848318	0.62518319856543	0.350067729679992	0.615305768848318	0.146753358106892
down	CNKSR3; WNK1; WNK4;	GO:2000651~positive regulation of sodium ion transmembrane transporter activity	3	8	37.5	0.00029751582193382	0.0177848346889331	0.629840995033907	0.640254048801591	0.354106056347284	0.629840995033907	0.146753358106892
down	PHGDH; RDH16; COX7A1; XDH; ME1; NDUFA4L2;	GO:0022900~electron transport chain	6	68	8.82352941176471	0.00033620536347922	0.0186327912550773	0.711074343758561	0.723513942207292	0.375205185642815	0.711074343758561	0.153750357279895
down	FABP12; CPS1; FABP5; MGLL;	GO:0019433~triglyceride catabolic process	4	23	17.3913043478261	0.00033767604969703	0.0186327912550773	0.713847169059528	0.726678858948016	0.375833443312798	0.713847169059528	0.153750357279895
down	SULT2B1; RDH16; CYP3A4; AKR1C2; DHCR24;	GO:0008202~steroid metabolic process	5	44	11.3636363636364	0.00036388347287652	0.0187506435778996	0.768885778188097	0.783077233630282	0.388627549032129	0.768521894715221	0.154722827614164
down	AKR1B10; RDH16; CYP3A4; RDH12; ADH7;	GO:0042572~retinol metabolic process	5	44	11.3636363636364	0.00036388347287652	0.0187506435778996	0.768885778188097	0.783077233630282	0.388627549032129	0.768521894715221	0.154722827614164
down	RDH16; CYP3A4; ALOX12; IL1RN; ALDH3B2; FABP5; MGLL; HSD17B10;	GO:0006629~lipid metabolic process	8	130	6.15384615384615	0.00036595122224525	0.0187506435778996	0.77252303015973	0.787527030271785	0.389589030010972	0.77252303015973	0.154722827614164
down	WNT9A; FZD7; WNT3; WNT4; WNT2B; PORCN;	GO:0060070~canonical Wnt signaling pathway	6	70	8.57142857142857	0.00038850486114505	0.0190782174645402	0.819745257016068	0.83606246118416	0.400548511840553	0.819745257016068	0.157425836595324
down	CXCL14; IL18; SOSTDC1; CCL17;	GO:0045662~negative regulation of myoblast differentiation	4	24	16.6666666666667	0.00039007507827126	0.0190782174645402	0.822668340074104	0.839441568439769	0.401284252061902	0.822668340074104	0.157425836595324
down	CRYAB; TH; NQO1; GJA1; PTN; GJB2; SLC6A1;	GO:0032355~response to estradiol	7	103	6.79611650485437	0.00048429297906338	0.0226564889335739	1	1	0.444580954780186	0.987576770761023	0.186952304706133
down	PLA2G4B; PLA2G2A; PLA2G4F; PLA2G4D;	GO:0036152~phosphatidylethanolamine acyl-chain remodeling	4	26	15.3846153846154	0.00051187273662056	0.0234372367916481	1	1	0.457333641474787	0.987576770761023	0.193394724442451
down	PRKAA2; BNIP3; TP53INP2; PLK2; MID2;	GO:0010508~positive regulation of autophagy	5	49	10.2040816326531	0.00057332478041838	0.0240827236746934	1	1	0.477006217308094	0.987576770761023	0.198721024594108
down	PLA2G4B; PLA2G2A; PLA2G4F; PLA2G4D;	GO:0036151~phosphatidylcholine acyl-chain remodeling	4	27	14.8148148148148	0.00058192454976024	0.0240827236746934	1	1	0.479505829002445	0.987576770761023	0.198721024594108
down	SCNN1B; SLC10A6; SLC38A4; SLC38A3; SLC6A15; SLC5A1;	GO:0006814~sodium ion transport	6	77	7.79220779220779	0.0006231965820076	0.0248355378607474	1	1	0.49107890662199	0.987576770761023	0.204932946816959
down	AGTR1; EPS8L1; EPS8L2; CTNNAL1; RHOD; RND3;	GO:0007266~Rho protein signal transduction	6	77	7.79220779220779	0.0006231965820076	0.0248355378607474	1	1	0.49107890662199	0.987576770761023	0.204932946816959
down	FUT3; FUT11; FUT6;	GO:0036065~fucosylation	3	11	27.2727272727273	0.00063822875054098	0.0249721503848035	1	1	0.49462728166926	0.987576770761023	0.206060218844805
down	RIMS2; SYT17; SYT7; SYT8;	GO:0017156~calcium-ion regulated exocytosis	4	29	13.7931034482759	0.00074198255352131	0.0283486349458968	1	1	0.519918042999509	0.987576770761023	0.233921621922386
down	EDN3; EDN2; PTN;	GO:0002690~positive regulation of leukocyte chemotaxis	3	12	25	0.0007903894501644	0.0283486349458968	1	1	0.531141710510482	0.987576770761023	0.233921621922386
down	CRYM; AADAT; SLC25A21;	GO:0006554~lysine catabolic process	3	12	25	0.0007903894501644	0.0283486349458968	1	1	0.531141710510482	0.987576770761023	0.233921621922386
down	MT2A; MT1A; MT1X;	GO:0010038~response to metal ion	3	12	25	0.0007903894501644	0.0283486349458968	1	1	0.531141710510482	0.987576770761023	0.233921621922386
down	TERT; GJA1; HMGA2;	GO:2000648~positive regulation of stem cell proliferation	3	12	25	0.0007903894501644	0.0283486349458968	1	1	0.531141710510482	0.987576770761023	0.233921621922386
down	NPR3; IL12A; CTNNBIP1; NDRG4;	GO:0048662~negative regulation of smooth muscle cell proliferation	4	30	13.3333333333333	0.00083265240164887	0.0293748847270224	1	1	0.541062436753988	0.987576770761023	0.242389825550412
up	IGKV3-7; IGLV4-69; IGLV8-61; IGLV1-50; IGLV7-46; IGLV2-18; IGLV3-10; TRBV19; TRGV2; IGKV2D-29; IGKV1-27; IGLV5-45; IGKV3D-15; IGKV1D-8; IGKV3D-11; IGLV5-52; IGKJ1; TRAV8-3; IGLV1-36; TRAV4; TRAV17; IGKV1D-13; IGKV6-21; TRGV8; TRGV4; IGKV3D-7; IGKV2-24; IGKV1-9; IGKV1-6; TRBJ1-6; TRBV5-1; TRBV28; TNFRSF13B; LILRA1; LILRB5; JCHAIN; HLA-DQA2; TRGV3; TRGC2; CD3D; CD3G; TRGC1; CD8B; CD1E; CTLA4; HLA-DMB; CD1B; CD1C; CD79B; TNFRSF17; SLAMF1; ADGRE1; TRAT1; BTNL8; SKAP1; CLEC10A; ZNF683; LILRB2; LILRB1; CLEC4C; FCAMR; FCGR1B; ORAI1; SIGLEC10; FCRL4; TRGV9; PDCD1LG2; CD209; CD84; CLEC4A; TNFSF18; LAMP3; SIT1;	GO:0002250~adaptive immune response	73	347	21.0374639769452	0.00085289059119531	0.212227608775766	1	1	0.99999999999995	0.99999999999995	1
down	DKK1; PDGFRA; PAX9; DLX5;	GO:0060325~face morphogenesis	4	31	12.9032258064516	0.00093085997798403	0.0313001667597131	1	1	0.559700649367298	0.987576770761023	0.258276484523747
down	MAPT; CAMSAP3; TUBB2A; TUBB6; MAP7D2; CALML3; TUBA4A;	GO:0000226~microtubule cytoskeleton organization	7	118	5.93220338983051	0.0010339601403716	0.0333058486251378	1	1	0.578065110901704	0.987576770761023	0.274826570830049
down	SLC6A15; SLC6A17; SLC6A1; SLC6A11;	GO:0006810~transport	4	32	12.5	0.00103693859567111	0.0333058486251378	1	1	0.57861173638448	0.987576770761023	0.274826570830049
down	COBL; PTN; VLDLR;	GO:1900006~positive regulation of dendrite development	3	14	21.4285714285714	0.00115946036329928	0.0366935103208831	1	1	0.598281547462429	0.987576770761023	0.302780203162099
down	SNCG; SYT7; SYT8; SYT17;	GO:0014059~regulation of dopamine secretion	4	34	11.7647058823529	0.00127404130256337	0.0391676697588052	1	1	0.61644085261212	0.987576770761023	0.323195979432028
down	OVOL1; DHCR24; ARRDC3; ABCB6;	GO:0043588~skin development	4	34	11.7647058823529	0.00127404130256337	0.0391676697588052	1	1	0.61644085261212	0.987576770761023	0.323195979432028
down	NSG1; ARC; CALB2;	GO:1900271~regulation of long-term synaptic potentiation	3	15	20	0.00137847743690189	0.0417814569607447	1	1	0.631416822615319	0.987576770761023	0.344763908286611
up	UGT2B11; UGT1A1; UGT1A3; UGT2B28; UGT1A7; UGT1A8; UGT1A6;	GO:0052697~xenobiotic glucuronidation	7	9	77.7777777777778	0.00155769164408104	0.36720530914942	1	1	0.99999999999995	0.99999999999995	1
down	NRG2; PDGFRA; AKR1C2; IL18; TNFAIP8L3; EPGN; KLB; FGF22;	GO:0051897~positive regulation of protein kinase B signaling	8	165	4.84848484848485	0.00159506626918982	0.0430879301861802	1	1	0.655547576481581	0.987576770761023	0.355544403942762
down	MIF; EDN2; PLA2G4F;	GO:0001516~prostaglandin biosynthetic process	3	16	18.75	0.00162180406369916	0.0430879301861802	1	1	0.65845244986186	0.987576770761023	0.355544403942762
down	CSTA; CSTB; ECM1;	GO:0010466~negative regulation of peptidase activity	3	16	18.75	0.00162180406369916	0.0430879301861802	1	1	0.65845244986186	0.987576770761023	0.355544403942762
down	EDN3; EDN2; AGTR1;	GO:0019229~regulation of vasoconstriction	3	16	18.75	0.00162180406369916	0.0430879301861802	1	1	0.65845244986186	0.987576770761023	0.355544403942762
down	SYT7; RIMS2; SYT8;	GO:0048791~calcium ion-regulated exocytosis of neurotransmitter	3	16	18.75	0.00162180406369916	0.0430879301861802	1	1	0.65845244986186	0.987576770761023	0.355544403942762
down	GPX3; GJB2; PRKAA2; RBM11; ERO1A; NOX5;	GO:0034599~cellular response to oxidative stress	6	94	6.38297872340426	0.00164715021849182	0.0432276496365171	1	1	0.660955303214881	0.987576770761023	0.356697313086334
down	GJA1; SCNN1B; CLCA4; ATP6V1C2; UNC79; GABRR1; CHRNA3; GABRQ; CHRNB4;	GO:0034220~ion transmembrane transport	9	208	4.32692307692308	0.00177043912489117	0.0459034336959733	1	1	0.674537306583534	0.987576770761023	0.378776815266833
down	PLA2G2A; AGTR1; IL18;	GO:0010744~positive regulation of macrophage derived foam cell differentiation	3	17	17.6470588235294	0.00189037150852633	0.0478597586629255	1	1	0.687582324449694	0.987576770761023	0.394919628144775
down	SPRY4; NRG2; BARX2;	GO:0048513~animal organ development	3	17	17.6470588235294	0.00189037150852633	0.0478597586629255	1	1	0.687582324449694	0.987576770761023	0.394919628144775
down	CFTR; GABRR1; SLC1A3; CLDN17; CLCA4; GABRQ;	GO:1902476~chloride transmembrane transport	6	97	6.18556701030928	0.00191475966110843	0.0479135208221552	1	1	0.689844686429579	0.987576770761023	0.395363252026809
down	MAL; PTPRZ1; ALDH5A1; POU6F2; NHLH2; SH3GL3; SPINK5;	GO:0007417~central nervous system development	7	133	5.26315789473684	0.00198505470398902	0.0488267872502039	1	1	0.696958860848253	0.987576770761023	0.402899162115747
down	PER1; WNK1; NKAIN1;	GO:0002028~regulation of sodium ion transport	3	18	16.6666666666667	0.00218506450910372	0.0496771940970469	1	1	0.717713782677365	0.987576770761023	0.409916380027194
down	SYT8; SYT7; SYT17;	GO:0017158~regulation of calcium ion-dependent exocytosis	3	18	16.6666666666667	0.00218506450910372	0.0496771940970469	1	1	0.717713782677365	0.987576770761023	0.409916380027194
down	SLC1A3; NMU; RIMS2;	GO:0050806~positive regulation of synaptic transmission	3	18	16.6666666666667	0.00218506450910372	0.0496771940970469	1	1	0.717713782677365	0.987576770761023	0.409916380027194
down	CFTR; PRKAA2; DHCR24; NPC1L1;	GO:0006695~cholesterol biosynthetic process	4	40	10	0.00220872541452055	0.0496771940970469	1	1	0.7200444851337	0.987576770761023	0.409916380027194
down	PLA2G4B; PLA2G2A; PLD1; PLA2G4D;	GO:0006654~phosphatidic acid biosynthetic process	4	41	9.75609756097561	0.00240051123425911	0.0508911970653839	1	1	0.730371164804223	0.987576770761023	0.419933848025705
down	TH; GJA1; GJB2; IL12A; CPS1; BDKRB1; S100A14;	GO:0032496~response to lipopolysaccharide	7	138	5.07246376811594	0.00241938705875255	0.0508911970653839	1	1	0.731363374341676	0.987576770761023	0.419933848025705
down	CACNA1G; CHRNA3; RIMS2; GABRQ; CHRNB4; GABRR1;	GO:0042391~regulation of membrane potential	6	102	5.88235294117647	0.00243223966644013	0.0508911970653839	1	1	0.732104139598479	0.987576770761023	0.419933848025705
down	TH; SPNS2; SERINC2;	GO:0006665~sphingolipid metabolic process	3	19	15.7894736842105	0.00250672253203099	0.0508911970653839	1	1	0.736031269211052	0.987576770761023	0.419933848025705
down	MAPT; SLC6A1; MAP1LC3A;	GO:0010288~response to lead ion	3	19	15.7894736842105	0.00250672253203099	0.0508911970653839	1	1	0.736031269211052	0.987576770761023	0.419933848025705
down	PLA2G2A; PLA2G4F; PLA2G4D;	GO:0036149~phosphatidylinositol acyl-chain remodeling	3	19	15.7894736842105	0.00250672253203099	0.0508911970653839	1	1	0.736031269211052	0.987576770761023	0.419933848025705
down	RHOD; PDGFRA; ESAM;	GO:2000249~regulation of actin cytoskeleton reorganization	3	19	15.7894736842105	0.00250672253203099	0.0508911970653839	1	1	0.736031269211052	0.987576770761023	0.419933848025705
down	TERT; HMGA2; PLK2;	GO:2000773~negative regulation of cellular senescence	3	19	15.7894736842105	0.00250672253203099	0.0508911970653839	1	1	0.736031269211052	0.987576770761023	0.419933848025705
down	EDN3; EDN2; NMU;	GO:0010460~positive regulation of heart rate	3	20	15	0.00285614100208409	0.0574431349204202	1	1	0.7540212245502	0.987576770761023	0.473997824393872
down	SRPX2; FGFBP1; PLK2;	GO:0090050~positive regulation of cell migration involved in sprouting angiogenesis	3	21	14.2857142857143	0.00323407250482355	0.0603702550915393	1	1	0.773424086622122	0.987576770761023	0.498151251862133
down	CDH16; DSG1; PCDHB16; PCDHB13;	GO:0016339~calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules	4	45	8.88888888888889	0.00328221182421473	0.0603702550915393	1	1	0.776141522602145	0.987576770761023	0.498151251862133
down	RHOD; AIF1L; RND3; PLS3;	GO:0051017~actin filament bundle assembly	4	45	8.88888888888889	0.00328221182421473	0.0603702550915393	1	1	0.776141522602145	0.987576770761023	0.498151251862133
up	BMPR1B; CCL21; FFAR3; NCR3; CD5L; IL18RAP; LY86; KNG1; CALCA; IL5; ADORA3; TMIGD3; FOLR2; ALOX15; SELP; SELE; IGFBP4; CRHBP; F2R; CD40LG; FCGR2B; CNR2; IL13; HRH1; LIPA; CSRP3; AIF1; NLRP6; TNFAIP6; MS4A2; FUT7; NAIP; NMI; NFATC4; PRKD1; GPR68; ZC3H12A; TRIL; PLD3; SCUBE1; TNIP2; PLD4; TNIP3; CD180; CCL19; RARRES2; NOX4; STAB1; MFHAS1; CCL11; CXCL6; PTGDR; ACKR1; CCL23; NFKB2; CXCL13; CCL16; CCL24; PTGER1; CCL14; RELB; GPR33; CCL26; TNFRSF4; IL36G; CCL13; CCR5; XCL1; CCL18; IL1F10; FPR3; CCR2; GGT5; XCL2; IL2RA;	GO:0006954~inflammatory response	75	381	19.6850393700787	0.00331371526767699	0.706768127805963	1	1	0.99999999999995	0.99999999999995	1
down	TERT; PTN; BNIP3; VASN; ERO1A; HILPDA;	GO:0071456~cellular response to hypoxia	6	111	5.40540540540541	0.00361961966307822	0.064759690715167	1	1	0.793373517427851	0.987576770761023	0.534371122849307
down	TH; SLC1A3; PER1;	GO:0009416~response to light stimulus	3	22	13.6363636363636	0.00364122796307398	0.064759690715167	1	1	0.794496419521108	0.987576770761023	0.534371122849307
down	KRT3; KRT6C; PPL;	GO:0045104~intermediate filament cytoskeleton organization	3	22	13.6363636363636	0.00364122796307398	0.064759690715167	1	1	0.794496419521108	0.987576770761023	0.534371122849307
down	NPR3; NOVA1; ARRDC3; HOXC10;	GO:0120163~negative regulation of cold-induced thermogenesis	4	47	8.51063829787234	0.00379611333108065	0.0669609499056194	1	1	0.802749749906544	0.987576770761023	0.552535035188823
down	FZD7; TYRO3; SRCIN1; LAMB4;	GO:0034446~substrate adhesion-dependent cell spreading	4	48	8.33333333333333	0.00407237953725781	0.0672024858824304	1	1	0.814948526521931	0.987576770761023	0.554528093674921
down	RHOD; CAMSAP3; LIMCH1;	GO:0051893~regulation of focal adhesion assembly	3	23	13.0434782608696	0.00407827778797087	0.0672024858824304	1	1	0.815655557594175	0.987576770761023	0.554528093674921
down	RASAL1; SYT17; RIMS2;	GO:1903861~positive regulation of dendrite extension	3	23	13.0434782608696	0.00407827778797087	0.0672024858824304	1	1	0.815655557594175	0.987576770761023	0.554528093674921
down	SNCG; NFASC; MAPT; PCDHGC5;	GO:0050808~synapse organization	4	49	8.16326530612245	0.00436191269283204	0.0695321193701818	1	1	0.826467518247999	0.987576770761023	0.573751299482875
down	YOD1; ERO1A; AMFR; CLGN;	GO:0030968~endoplasmic reticulum unfolded protein response	4	50	8	0.00466499972591139	0.0732779518989877	1	1	0.838498960282964	0.987576770761023	0.604660414587013
down	MAPT; PTN; PLK2; RIMS2;	GO:0048167~regulation of synaptic plasticity	4	50	8	0.00466499972591139	0.0732779518989877	1	1	0.838498960282964	0.987576770761023	0.604660414587013
up	CCR2; CCR5; GPR17; ACKR1; GPR35; CCL26; CCL23; CCL16; CCL21; CCL11; CCL13; CCL24; CCL14; TFF2; XCL2; CXCL13; CXCL6; XCL1; CCL18; CCL19;	GO:0070098~chemokine-mediated signaling pathway	20	70	28.5714285714286	0.00468714512343327	0.912770565559026	1	1	0.99999999999995	0.99999999999995	1
down	TH; MAPT; PTN; VLDLR; PLK2;	GO:0007613~memory	5	83	6.02409638554217	0.00502261372286461	0.0745206593475859	1	1	0.848503391902224	0.987576770761023	0.614914740500973
down	IL20RB; IL36A; IL1RN;	GO:0002437~inflammatory response to antigenic stimulus	3	25	12	0.00504454635644347	0.0745206593475859	1	1	0.848503391902224	0.987576770761023	0.614914740500973
down	CYP3A4; BCO2; ADH7;	GO:0042573~retinoic acid metabolic process	3	25	12	0.00504454635644347	0.0745206593475859	1	1	0.848503391902224	0.987576770761023	0.614914740500973
down	GJA1; PTN; GJB2;	GO:0046697~decidualization	3	25	12	0.00504454635644347	0.0745206593475859	1	1	0.848503391902224	0.987576770761023	0.614914740500973
up	TFPI; PCK1; SOX9; ADAMTS12; PTGIS; ZC3H12A; SFRP1; NLRP7; HAS2; ADAMTS7; CCL16; XCL2; CCL13; CCL14; CCL21; XCL1; CCL26; CCL11; CCL24; CCL18; CCL23; CCL19;	GO:0071347~cellular response to interleukin-1	22	81	27.1604938271605	0.00516617951173348	0.964138251377261	1	1	0.99999999999995	0.99999999999995	1
down	NRTN; EPHA6; PTK6; TYRO3; PDGFRA; ROR1;	GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway	6	120	5	0.00519110402261613	0.0745206593475859	1	1	0.851341059709046	0.987576770761023	0.614914740500973
down	AR; WWTR1; SLITRK6; ETNK2; UNC79;	GO:0035264~multicellular organism growth	5	84	5.95238095238095	0.00526795179687634	0.0745206593475859	1	1	0.852896530765623	0.987576770761023	0.614914740500973
down	GABRQ; CHRNB4; GABRR1; CHRNA3;	GO:0050877~nervous system process	4	52	7.69230769230769	0.00531295981959978	0.0745206593475859	1	1	0.853559232032729	0.987576770761023	0.614914740500973
down	NQO1; CHRNA3; CHRNB4;	GO:0007271~synaptic transmission, cholinergic	3	26	11.5384615384615	0.00557491337654414	0.0769052152969423	1	1	0.85847101789481	0.987576770761023	0.634591144543097
down	FZD7; AR; MIF;	GO:0042327~positive regulation of phosphorylation	3	26	11.5384615384615	0.00557491337654414	0.0769052152969423	1	1	0.85847101789481	0.987576770761023	0.634591144543097
down	CRYAB; TH; ALDH3A1; PSEN2; HSD11B2; BNIP3; PLEKHN1;	GO:0001666~response to hypoxia	7	163	4.29447852760736	0.00577896923962429	0.0792123681762514	1	1	0.861511647238003	0.987576770761023	0.653628849341966
down	PLA2G4B; ALOX12; MGLL;	GO:0019369~arachidonic acid metabolic process	3	27	11.1111111111111	0.00613747344760407	0.0811978410015504	1	1	0.868181414829523	0.987576770761023	0.670012178714374
down	WWC1; WWTR1; AMOTL2;	GO:0035329~hippo signaling	3	27	11.1111111111111	0.00613747344760407	0.0811978410015504	1	1	0.868181414829523	0.987576770761023	0.670012178714374
down	TH; NQO1; EEF1A2;	GO:0051602~response to electrical stimulus	3	27	11.1111111111111	0.00613747344760407	0.0811978410015504	1	1	0.868181414829523	0.987576770761023	0.670012178714374
down	MIF; PLA2G2A; PDGFRA; TNFAIP8L3; NDRG4; CCL17; CCL22; ROR1;	GO:0070374~positive regulation of ERK1 and ERK2 cascade	8	209	3.82775119617225	0.00630233348383658	0.0811978410015504	1	1	0.870909956116963	0.987576770761023	0.670012178714374
down	WNT3; WNT2B; WNT4; WNT9A;	GO:0045165~cell fate commitment	4	55	7.27272727272727	0.00639345324764196	0.0811978410015504	1	1	0.872805413369863	0.987576770761023	0.670012178714374
down	LGI3; SRCIN1; SYTL5; RAB25; STX19;	GO:0006887~exocytosis	5	90	5.55555555555556	0.00692048595973516	0.0851022044877146	1	1	0.882187926771715	0.987576770761023	0.702229428010544
up	CCL21; AIF1; CCL19; RARRES2; SUCNR1; P2RY12; TREM2; CCL26;	GO:0050921~positive regulation of chemotaxis	8	17	47.0588235294118	0.00718177117801921	0.972193431489622	1	1	0.99999999999995	0.99999999999995	1
down	OTX1; DLX5; USH1G; TMIE;	GO:0042472~inner ear morphogenesis	4	57	7.01754385964912	0.00718921151588603	0.0874078145886256	1	1	0.886869348552933	0.987576770761023	0.721254402417779
down	SLC6A1; TNNT2; TRPC1; S100A16;	GO:0051592~response to calcium ion	4	57	7.01754385964912	0.00718921151588603	0.0874078145886256	1	1	0.886869348552933	0.987576770761023	0.721254402417779
down	WNT9A; FZD7; EDN3; WNT3; WNT2B; WNT4;	GO:0030182~neuron differentiation	6	131	4.58015267175572	0.00772915761033932	0.0908708614485522	1	1	0.896582282799361	0.987576770761023	0.749830083039202
down	UNC13B; GJA1; SLC1A3;	GO:0014047~glutamate secretion	3	30	10	0.00802298497919374	0.0908708614485522	1	1	0.901775981066811	0.987576770761023	0.749830083039202
down	LGI3; RIMS2; PCLO;	GO:0017157~regulation of exocytosis	3	30	10	0.00802298497919374	0.0908708614485522	1	1	0.901775981066811	0.987576770761023	0.749830083039202
down	BNIP3; DIO2; ERO1A;	GO:0050873~brown fat cell differentiation	3	30	10	0.00802298497919374	0.0908708614485522	1	1	0.901775981066811	0.987576770761023	0.749830083039202
down	GSTA4; CYP3A4; NQO1; ALDH3A1; FMO2;	GO:0006805~xenobiotic metabolic process	5	94	5.31914893617021	0.00820463387158665	0.0924417386997617	1	1	0.904865136582883	0.987576770761023	0.762792335195089
down	EDN3; MIF; TPD52L1; EPGN;	GO:0043406~positive regulation of MAP kinase activity	4	60	6.66666666666667	0.00850097186361609	0.095281726304697	1	1	0.909756299483331	0.987576770761023	0.78622677950092
down	WNT9A; CDKN2B; PLK2;	GO:0007093~mitotic cell cycle checkpoint	3	31	9.67741935483871	0.00871882361571719	0.0972171420778414	1	1	0.914295913009325	0.987576770761023	0.802197058056206
down	CHRNB4; CHRNA3; SLC1A3; WNK4; WNK1;	GO:0006811~ion transport	5	96	5.20833333333333	0.00890480562452867	0.0987790809483799	1	1	0.916985064185217	0.987576770761023	0.815085554262012
down	GJA1; ACADL; FABP5; IL18; DIO2;	GO:0120162~positive regulation of cold-induced thermogenesis	5	97	5.15463917525773	0.0092698908578206	0.0989437055845678	1	1	0.92039796747963	0.987576770761023	0.816443971059821
down	CNN3; LIMCH1; EPB41L3;	GO:0031032~actomyosin structure organization	3	32	9.375	0.00944894520676565	0.0989437055845678	1	1	0.922489781042084	0.987576770761023	0.816443971059821
down	MAPT; PRKAA2; CAMSAP3;	GO:0070507~regulation of microtubule cytoskeleton organization	3	32	9.375	0.00944894520676565	0.0989437055845678	1	1	0.922489781042084	0.987576770761023	0.816443971059821
down	TH; PTN; SLC6A1; ARC;	GO:0007612~learning	4	62	6.45161290322581	0.00945696928689088	0.0989437055845678	1	1	0.922489781042084	0.987576770761023	0.816443971059821
down	IL12A; BDKRB1; PTK6; ARC; WWC1; TYRO3; LAMB4; RHOD;	GO:0016477~cell migration	8	225	3.55555555555556	0.00947137702157108	0.0989437055845678	1	1	0.922489781042084	0.987576770761023	0.816443971059821
up	UGT1A1; UGT1A3; UGT1A7; UGT1A8; UGT1A6;	GO:0052696~flavonoid glucuronidation	5	7	71.4285714285714	0.00965605216133425	0.972193431489622	1	1	0.99999999999995	0.99999999999995	1
down	AKR1B10; ADH7; RDH12; BCO2;	GO:0001523~retinoid metabolic process	4	63	6.34920634920635	0.00996008577346075	0.103048579733113	1	1	0.926972238675913	0.987576770761023	0.8503157543202
down	OTX1; ARC; PCSK5; CTNNBIP1; HOXC10;	GO:0009952~anterior/posterior pattern specification	5	99	5.05050505050505	0.0100307218072331	0.103282838895529	1	1	0.928160359976446	0.987576770761023	0.852248767438013
down	RHOD; ARHGEF4; ABLIM2;	GO:0030032~lamellipodium assembly	3	33	9.09090909090909	0.0102136730805313	0.104169784214708	1	1	0.929444250328352	0.987576770761023	0.859567486241046
down	IL1RN; RIMS2; PCLO;	GO:0030073~insulin secretion	3	33	9.09090909090909	0.0102136730805313	0.104169784214708	1	1	0.929444250328352	0.987576770761023	0.859567486241046
down	TSPAN6; GJA1; ROR1; ECM1; PLK2; MID2; IL36A;	GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling	7	183	3.82513661202186	0.0103347437812884	0.104907399138362	1	1	0.930624611562737	0.987576770761023	0.865653990216438
down	SRPX2; IL18; ECM1; EPGN; CXCL17; UNC5B; NOX5; AMOTL2;	GO:0001525~angiogenesis	8	230	3.47826086956522	0.010670025910831	0.107795102493919	1	1	0.934557936210086	0.987576770761023	0.889482165853532
down	RHOD; TRIP10; SRGAP1; NGEF; ARHGEF4; ARHGAP28;	GO:0051056~regulation of small GTPase mediated signal transduction	6	141	4.25531914893617	0.0107194014561797	0.107795102493919	1	1	0.934557936210086	0.987576770761023	0.889482165853532
down	TUBA4A; TUBB6; TUBB2A;	GO:0007017~microtubule-based process	3	34	8.82352941176471	0.0110133011646425	0.108588827228367	1	1	0.937352666880571	0.987576770761023	0.896031665594752
down	SLC6A15; SLC38A3; SLC38A4;	GO:0003333~amino acid transmembrane transport	3	35	8.57142857142857	0.0118480948672144	0.114851802496601	1	1	0.946695052264762	0.987576770761023	0.947711238018645
down	EDN2; NMU; PRKAA2;	GO:0097009~energy homeostasis	3	35	8.57142857142857	0.0118480948672144	0.114851802496601	1	1	0.946695052264762	0.987576770761023	0.947711238018645
down	TH; GJA1; PTN; PCSK5; ALPK3; FLRT3; PDLIM2;	GO:0007507~heart development	7	190	3.68421052631579	0.0124200123005174	0.118636141387862	1	1	0.951993718602065	0.987576770761023	0.978938092258271
down	ZBTB7C; OVOL1; PER1; AR; OTX1; CDKN2B; ETV1; HMGA2; PAX9; ELF3; NHLH2; IL18; AKNAD1; VGLL2; TFAP2C; WWTR1; HOXC10; GRHL1; BARX2; LPIN3; POU6F2; DLX5; ZBED2; POU3F1;	GO:0045944~positive regulation of transcription by RNA polymerase II	24	1138	2.10896309314587	0.0125333369231267	0.118636141387862	1	1	0.952533606157633	0.987576770761023	0.978938092258271
down	TERT; WNT3; ATP6V1C2;	GO:0030177~positive regulation of Wnt signaling pathway	3	36	8.33333333333333	0.012718291936628	0.118636141387862	1	1	0.953871895247099	0.987576770761023	0.978938092258271
down	WNT9A; AR; EDN3;	GO:0045597~positive regulation of cell differentiation	3	36	8.33333333333333	0.012718291936628	0.118636141387862	1	1	0.953871895247099	0.987576770761023	0.978938092258271
down	A2ML1; CSTA; CSTB; CST6; SERPINB12; SERPINB5;	GO:0010951~negative regulation of endopeptidase activity	6	148	4.05405405405405	0.0132473777161249	0.121160332168121	1	1	0.959843594657329	0.987576770761023	0.999766707198164
down	GHR; IL12A; PTK6; IL18;	GO:0042531~positive regulation of tyrosine phosphorylation of STAT protein	4	69	5.79710144927536	0.0133434008939799	0.121160332168121	1	1	0.960724864366552	0.987576770761023	0.999766707198164
down	WNT9A; FZD7; WNT3; PTK6;	GO:0071300~cellular response to retinoic acid	4	69	5.79710144927536	0.0133434008939799	0.121160332168121	1	1	0.960724864366552	0.987576770761023	0.999766707198164
down	HMGA2; GPLD1; WNT2B;	GO:0002062~chondrocyte differentiation	3	37	8.10810810810811	0.0136241033037425	0.123189371048966	1	1	0.964154592163088	0.987576770761023	1
down	PDGFRA; GJA1; EDN2; AGTR1; BDKRB1; NMU;	GO:0007204~positive regulation of cytosolic calcium ion concentration	6	150	4	0.0140401091519718	0.124576714856281	1	1	0.968757860686187	0.987576770761023	1
down	BNIP3; MAP1LC3A; ATG9B;	GO:0000422~autophagy of mitochondrion	3	38	7.89473684210526	0.0145657139038283	0.124576714856281	1	1	0.971092638619758	0.987576770761023	1
down	CACNA1G; KCNJ5; DSC2;	GO:0086091~regulation of heart rate by cardiac conduction	3	38	7.89473684210526	0.0145657139038283	0.124576714856281	1	1	0.971092638619758	0.987576770761023	1
down	YOD1; AMFR; NCCRP1; FBXO27;	GO:0030433~ubiquitin-dependent ERAD pathway	4	71	5.63380281690141	0.0146146165682086	0.124576714856281	1	1	0.971092638619758	0.987576770761023	1
up	GREM1; PTH; RARB; BMP4; SOX9; ADAMTS12; NKX3-2; ADAMTS7;	GO:0032331~negative regulation of chondrocyte differentiation	8	20	40	0.0148637220497326	0.972193431489622	1	1	0.99999999999995	0.99999999999995	1
up	CCL24; HRH1; CCL11; CCL13; CCL18; CCL23; XCL1; XCL2;	GO:0048245~eosinophil chemotaxis	8	20	40	0.0148637220497326	0.972193431489622	1	1	0.99999999999995	0.99999999999995	1
down	SASH1; RNF180; ZNRF1; FBXO27; RMND5A; FBXO10; AMFR; TRIM2;	GO:0000209~protein polyubiquitination	8	245	3.26530612244898	0.0149397066760418	0.124576714856281	1	1	0.971315622004056	0.987576770761023	1
down	WNT4; DSC2; WNT2B; MAP1LC3A;	GO:0009267~cellular response to starvation	4	72	5.55555555555556	0.0152779033703541	0.124576714856281	1	1	0.971782825285444	0.987576770761023	1
down	PTN; CAMK2B; PTK6; NDRG4; ROR1;	GO:0010976~positive regulation of neuron projection development	5	111	4.5045045045045	0.0155068103237148	0.124576714856281	1	1	0.972027730231332	0.987576770761023	1
down	DHCR24; BARX2; LAMB4;	GO:0009888~tissue development	3	39	7.69230769230769	0.01554328348028	0.124576714856281	1	1	0.972027730231332	0.987576770761023	1
down	RGS11; PTK6; RGS17;	GO:0009968~negative regulation of signal transduction	3	39	7.69230769230769	0.01554328348028	0.124576714856281	1	1	0.972027730231332	0.987576770761023	1
down	DKK1; DLX5; HOXC10;	GO:0030326~embryonic limb morphogenesis	3	39	7.69230769230769	0.01554328348028	0.124576714856281	1	1	0.972027730231332	0.987576770761023	1
up	TYROBP; CTLA4; IL10; FCGR2B; MNDA; CD300A; TNFRSF13B;	GO:0030889~negative regulation of B cell proliferation	7	16	43.75	0.0156318522030532	0.972193431489622	1	1	0.99999999999995	0.99999999999995	1
up	TRPM2; GATA1; FLT3; LILRB1; BATF3; TREM2;	GO:0097028~dendritic cell differentiation	6	12	50	0.0156432965401362	0.972193431489622	1	1	0.99999999999995	0.99999999999995	1
down	TYRO3; ROR1; PDGFRA; EPHA6;	GO:0033674~positive regulation of kinase activity	4	73	5.47945205479452	0.0159598544527266	0.124576714856281	1	1	0.972542030617698	0.987576770761023	1
down	HMGA2; WNT4; AKNAD1;	GO:0001837~epithelial to mesenchymal transition	3	40	7.5	0.0165569473694647	0.124576714856281	1	1	0.973091799996227	0.987576770761023	1
down	PRKAA2; FADS6; MGLL;	GO:0006633~fatty acid biosynthetic process	3	40	7.5	0.0165569473694647	0.124576714856281	1	1	0.973091799996227	0.987576770761023	1
down	SYNPO2L; MYOZ1; TNNT2;	GO:0045214~sarcomere organization	3	40	7.5	0.0165569473694647	0.124576714856281	1	1	0.973091799996227	0.987576770761023	1
down	USH1G; CDHR1; RDH12;	GO:0045494~photoreceptor cell maintenance	3	40	7.5	0.0165569473694647	0.124576714856281	1	1	0.973091799996227	0.987576770761023	1
down	DHCR24; PHYHIP; WNK4; AKAP3;	GO:0008104~protein localization	4	74	5.40540540540541	0.0166606208586304	0.124576714856281	1	1	0.973091799996227	0.987576770761023	1
down	RND3; TRIP10; ABLIM2; SPTBN5; PDLIM2; AMOTL2;	GO:0030036~actin cytoskeleton organization	6	157	3.82165605095541	0.017074303254753	0.124576714856281	1	1	0.973381152300716	0.987576770761023	1
down	TERT; MAPT; MIF; XDH; PRKAA2; WNT4; UPK3B;	GO:0010629~negative regulation of gene expression	7	204	3.43137254901961	0.017471036875378	0.124576714856281	1	1	0.973991422615638	0.987576770761023	1
up	CCL21; FGF10; RAMP3; RASGRP1; APOE; NTRK1; BMP4; DRD2; ALOX15; ADCYAP1; FSHR; F2R; FLT4; CHRNA7; THPO; CASR; HTR2B; GATA4; SLAMF1; ANGPT1; SYT14P1; SCIMP; SLC30A10; GCNT2; CCL19; CIB1; NOX4; TREM2; MFHAS1; CCL11; HMGB1P1; XCL1; CCL24; CCL14; ROR2; XCL2; CCL13; CCL26; NTRK2; CCL18; CCL23; CCL16;	GO:0070374~positive regulation of ERK1 and ERK2 cascade	42	209	20.0956937799043	0.0174802955314239	0.972193431489622	1	1	0.99999999999995	0.99999999999995	1
down	CRYAB; WNT2B; SLITRK6;	GO:0002088~lens development in camera-type eye	3	41	7.31707317073171	0.0176068172685261	0.124576714856281	1	1	0.973991422615638	0.987576770761023	1
down	SLC38A4; SLC38A3; SLC6A15;	GO:0006865~amino acid transport	3	41	7.31707317073171	0.0176068172685261	0.124576714856281	1	1	0.973991422615638	0.987576770761023	1
down	PDE6A; TRPC1; CALB2;	GO:0051480~regulation of cytosolic calcium ion concentration	3	41	7.31707317073171	0.0176068172685261	0.124576714856281	1	1	0.973991422615638	0.987576770761023	1
down	PHGDH; MAPT; NRTN; FLRT3; CAMSAP3;	GO:0031175~neuron projection development	5	115	4.34782608695652	0.0177016385220591	0.124576714856281	1	1	0.973991422615638	0.987576770761023	1
down	ANXA2P2; CACNA1G; TRPC1; TMC1; TMEM37;	GO:0070588~calcium ion transmembrane transport	5	115	4.34782608695652	0.0177016385220591	0.124576714856281	1	1	0.973991422615638	0.987576770761023	1
down	EDN3; EDN2; CCL22; CCL17;	GO:0030593~neutrophil chemotaxis	4	76	5.26315789473684	0.0181191730849087	0.124576714856281	1	1	0.974647751067535	0.987576770761023	1
down	MIF; PTN; WNT4; LIMCH1; SRGAP1;	GO:0030336~negative regulation of cell migration	5	116	4.31034482758621	0.0182807287374807	0.124576714856281	1	1	0.974647751067535	0.987576770761023	1
down	COX7A1; OTOP2; ATP6V1C2; NOX5; NDUFA4L2;	GO:1902600~proton transmembrane transport	5	116	4.31034482758621	0.0182807287374807	0.124576714856281	1	1	0.974647751067535	0.987576770761023	1
down	PTN; GJB2; DSG1;	GO:0032570~response to progesterone	3	42	7.14285714285714	0.0186929819853678	0.124576714856281	1	1	0.974994847844981	0.987576770761023	1
down	DKK1; ADH7; DKK2;	GO:2000272~negative regulation of signaling receptor activity	3	42	7.14285714285714	0.0186929819853678	0.124576714856281	1	1	0.974994847844981	0.987576770761023	1
up	APOA1; APOE; APOC3; APOA4; GPIHBP1;	GO:0034371~chylomicron remodeling	5	9	55.5555555555556	0.0198680985922257	0.972193431489622	1	1	0.99999999999995	0.99999999999995	1
down	FGFBP1; KLB; FGF22; FLRT3;	GO:0008543~fibroblast growth factor receptor signaling pathway	4	79	5.06329113924051	0.0204515393591731	0.124576714856281	1	1	0.976951882866749	0.987576770761023	1
up	FGF10; MDK; FGF7; CDH3; REG3A; HAS2;	GO:0010838~positive regulation of keratinocyte proliferation	6	13	46.1538461538462	0.0205794136968185	0.972193431489622	1	1	0.99999999999995	0.99999999999995	1
down	TF; CGNL1; RND3; RHOD; MYO5C;	GO:0007015~actin filament organization	5	121	4.13223140495868	0.0213632593331967	0.124576714856281	1	1	0.977856467943477	0.987576770761023	1
down	PLA2G2A; PLD1; ASPG; PNLIPRP3;	GO:0016042~lipid catabolic process	4	81	4.93827160493827	0.0221042135844954	0.124576714856281	1	1	0.978339598609458	0.987576770761023	1
down	PTN; ARC; PLK2;	GO:0060291~long-term synaptic potentiation	3	45	6.66666666666667	0.0221698050389647	0.124576714856281	1	1	0.978339598609458	0.987576770761023	1
down	TGM5; TGM1; TGM3; ERO1A;	GO:0006464~cellular protein modification process	4	82	4.8780487804878	0.0229602044837723	0.124576714856281	1	1	0.979374878607986	0.987576770761023	1
down	PHGDH; SLC6A11; CTTNBP2; SLC38A3; SLC6A17; ABCB6; NDRG4;	GO:0007420~brain development	7	217	3.2258064516129	0.0233201576772866	0.124576714856281	1	1	0.979446622446036	0.987576770761023	1
down	DKK1; GJA1; GJB2;	GO:0032526~response to retinoic acid	3	46	6.52173913043478	0.0234016045964955	0.124576714856281	1	1	0.979930394704758	0.987576770761023	1
down	CXCL14; GJB2; ROR1;	GO:0048839~inner ear development	3	46	6.52173913043478	0.0234016045964955	0.124576714856281	1	1	0.979930394704758	0.987576770761023	1
down	PLS3; GJA1; SPNS2;	GO:0060348~bone development	3	46	6.52173913043478	0.0234016045964955	0.124576714856281	1	1	0.979930394704758	0.987576770761023	1
up	APOA1; IL10; ANGPT1; LILRB1;	GO:0002740~negative regulation of cytokine secretion involved in immune response	4	6	66.6666666666667	0.024258274528306	0.972193431489622	1	1	0.99999999999995	0.99999999999995	1
up	FOXF1; IL13RA2; CD300A; CD84;	GO:0043305~negative regulation of mast cell degranulation	4	6	66.6666666666667	0.024258274528306	0.972193431489622	1	1	0.99999999999995	0.99999999999995	1
up	FCGR2B; TMEM176B; LILRB1; TMEM176A;	GO:2001199~negative regulation of dendritic cell differentiation	4	6	66.6666666666667	0.024258274528306	0.972193431489622	1	1	0.99999999999995	0.99999999999995	1
down	DKK1; SOSTDC1; CTNNBIP1;	GO:0030178~negative regulation of Wnt signaling pathway	3	47	6.38297872340426	0.0246698247194008	0.124576714856281	1	1	0.981126890913188	0.987576770761023	1
up	BMP5; CSRP3; TBX2; SGCG; GATA4; SGCD; GATA5;	GO:0048738~cardiac muscle tissue development	7	18	38.8888888888889	0.0247404533488776	0.972193431489622	1	1	0.99999999999995	0.99999999999995	1
down	PDGFRA; TYRO3; CAMK2B; PTK6; ULK3; STK33;	GO:0046777~protein autophosphorylation	6	173	3.46820809248555	0.0256348487463218	0.126592529941413	1	1	0.981772369130894	0.987576770761023	1
down	PLA2G4B; EDN2; AGTR1; CALML3;	GO:0019722~calcium-mediated signaling	4	85	4.70588235294118	0.0256479289286505	0.126592529941413	1	1	0.981772369130894	0.987576770761023	1
down	SNCG; CSTB; SLITRK6;	GO:0008344~adult locomotory behavior	3	48	6.25	0.0259744316811836	0.127910702466607	1	1	0.982452738063071	0.987576770761023	1
up	CCL21; IGF1; CCL19;	GO:0010560~positive regulation of glycoprotein biosynthetic process	3	3	100	0.0263756678837286	0.972193431489622	1	1	0.99999999999995	0.99999999999995	1
up	PAX6; NKX6-1; NKX6-2;	GO:0021912~regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification	3	3	100	0.0263756678837286	0.972193431489622	1	1	0.99999999999995	0.99999999999995	1
up	MYO7B; ANKS4B; USH1C;	GO:1904970~brush border assembly	3	3	100	0.0263756678837286	0.972193431489622	1	1	0.99999999999995	0.99999999999995	1
up	LILRA5; LILRB1; TLR8;	GO:2001183~negative regulation of interleukin-12 secretion	3	3	100	0.0263756678837286	0.972193431489622	1	1	0.99999999999995	0.99999999999995	1
up	P2RY10; GPR171; P2RY4; P2RY13; P2RY12; GPR34;	GO:0035589~G protein-coupled purinergic nucleotide receptor signaling pathway	6	14	42.8571428571429	0.0264716544767795	0.972193431489622	1	1	0.99999999999995	0.99999999999995	1
up	UGT2B17; UGT1A6; UGT1A1; UGT1A4; UGT1A3; UGT1A7;	GO:0052695~cellular glucuronidation	6	14	42.8571428571429	0.0264716544767795	0.972193431489622	1	1	0.99999999999995	0.99999999999995	1
down	TH; CHRNB4; CHRNA3; NOVA1;	GO:0007626~locomotory behavior	4	87	4.59770114942529	0.0275403665625453	0.132998274141924	1	1	0.983930110601512	0.987576770761023	1
down	PDGFRA; IL18; UNC5B; ROR1;	GO:0014068~positive regulation of phosphatidylinositol 3-kinase signaling	4	87	4.59770114942529	0.0275403665625453	0.132998274141924	1	1	0.983930110601512	0.987576770761023	1
down	IL12A; CDKN2B; PRKAA2; DHCR24; CAB39L;	GO:0007050~cell cycle arrest	5	131	3.81679389312977	0.0284974679600828	0.132998274141924	1	1	0.984733975070957	0.987576770761023	1
down	TERT; SASH1; HMGA2; ECM1; CCBE1;	GO:0045766~positive regulation of angiogenesis	5	131	3.81679389312977	0.0284974679600828	0.132998274141924	1	1	0.984733975070957	0.987576770761023	1
down	FOXP2; VGLL2; MYOZ1;	GO:0007519~skeletal muscle tissue development	3	50	6	0.0286925813065659	0.132998274141924	1	1	0.984733975070957	0.987576770761023	1
down	DLG2; WNK1; CAMSAP3;	GO:0010923~negative regulation of phosphatase activity	3	50	6	0.0286925813065659	0.132998274141924	1	1	0.984733975070957	0.987576770761023	1
down	EGFL8; ROR1; TFAP2C;	GO:0048856~anatomical structure development	3	50	6	0.0286925813065659	0.132998274141924	1	1	0.984733975070957	0.987576770761023	1
down	FUT3; FUT6; FUT11; B3GNT8;	GO:0006486~protein glycosylation	4	90	4.44444444444444	0.0305313475825697	0.132998274141924	1	1	0.98649242859787	0.987576770761023	1
down	TF; CFTR; DHCR24; TRIP10; EPGN;	GO:0061024~membrane organization	5	134	3.73134328358209	0.0308982932566615	0.132998274141924	1	1	0.987456741822306	0.987576770761023	1
down	WNT4; SYNPO2L; LIMCH1;	GO:0051496~positive regulation of stress fiber assembly	3	52	5.76923076923077	0.0315554326233699	0.132998274141924	1	1	0.987456741822306	0.987576770761023	1
down	CAP2; RHOD; RND3;	GO:0007163~establishment or maintenance of cell polarity	3	53	5.66037735849057	0.0330408556123111	0.132998274141924	1	1	0.987576770761023	0.987576770761023	1
down	BDKRB1; NMU; DLG2;	GO:0019233~sensory perception of pain	3	53	5.66037735849057	0.0330408556123111	0.132998274141924	1	1	0.987576770761023	0.987576770761023	1
down	NFASC; MAL; FAM126A;	GO:0042552~myelination	3	53	5.66037735849057	0.0330408556123111	0.132998274141924	1	1	0.987576770761023	0.987576770761023	1
down	CALML3; RNF180; GRPEL2;	GO:0050790~regulation of catalytic activity	3	53	5.66037735849057	0.0330408556123111	0.132998274141924	1	1	0.987576770761023	0.987576770761023	1
up	MUC2; MUC6; MUC4; TFF3; TFF2; TFF1;	GO:0030277~maintenance of gastrointestinal epithelium	6	15	40	0.0333818099750465	0.972193431489622	1	1	0.99999999999995	0.99999999999995	1
up	GRM6; GRIK3; GRM7; GRM4;	GO:0007196~adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway	4	7	57.1428571428571	0.0345504385225478	0.972193431489622	1	1	0.99999999999995	0.99999999999995	1
up	CYP2A6; UGT1A7; UGT1A8; CYP2A7;	GO:0009804~coumarin metabolic process	4	7	57.1428571428571	0.0345504385225478	0.972193431489622	1	1	0.99999999999995	0.99999999999995	1
down	SASH1; GPLD1; CCBE1;	GO:0010595~positive regulation of endothelial cell migration	3	54	5.55555555555556	0.0345621040912487	0.132998274141924	1	1	0.987576770761023	0.987576770761023	1
down	OVOL1; AGTR1; WNT4; PCSK5;	GO:0001822~kidney development	4	94	4.25531914893617	0.0348058614610989	0.132998274141924	1	1	0.987576770761023	0.987576770761023	1
down	KRT13; KRT76; KRT31; ARC; PCLO;	GO:0007010~cytoskeleton organization	5	139	3.59712230215827	0.0351740851621219	0.132998274141924	1	1	0.987576770761023	0.987576770761023	1
up	THY1; RP1; CABP4; RORB; USH1C;	GO:0046549~retinal cone cell development	5	11	45.4545454545455	0.0353442212713294	0.972193431489622	1	1	0.99999999999995	0.99999999999995	1
down	WWTR1; NCCRP1; FBXO27; FBXO39;	GO:0031146~SCF-dependent proteasomal ubiquitin-dependent protein catabolic process	4	95	4.21052631578947	0.0359259131488459	0.132998274141924	1	1	0.987576770761023	0.987576770761023	1
down	PLA2G2A; IL12A; RNASE7; GBP6;	GO:0050830~defense response to Gram-positive bacterium	4	95	4.21052631578947	0.0359259131488459	0.132998274141924	1	1	0.987576770761023	0.987576770761023	1
down	SYT7; HSPA2; SYT17; SYT8; ARL4D;	GO:0016192~vesicle-mediated transport	5	141	3.54609929078014	0.036981563068225	0.132998274141924	1	1	0.987576770761023	0.987576770761023	1
down	IL12A; DLX5; IL18; FAM83A; SDCBP2;	GO:0008283~cell population proliferation	5	142	3.52112676056338	0.0379062870688102	0.135957216286799	1	1	0.987576770761023	0.987576770761023	1
up	UGT1A1; UGT1A3; ALDH1A3; UGT1A7; UGT1A8; ADH1B; ADH1C; ADH1A;	GO:0042573~retinoic acid metabolic process	8	25	32	0.038619633191741	0.972193431489622	1	1	0.99999999999995	0.99999999999995	1
up	TNFSF11; FGF10; AGT; APOA1; IGF1; SULT1A3; HTR2B; SOX9; CCL11;	GO:0070371~ERK1 and ERK2 cascade	9	30	30	0.0390987535741827	0.972193431489622	1	1	0.99999999999995	0.99999999999995	1
down	PPL; SCEL; BDKRB1;	GO:0009612~response to mechanical stimulus	3	57	5.26315789473684	0.0393392534308987	0.140162373151149	1	1	0.987576770761023	0.987576770761023	1
down	SCEL; DLX5; WNK1; DKK2; ZBED2;	GO:0090263~positive regulation of canonical Wnt signaling pathway	5	144	3.47222222222222	0.0397978812119015	0.141562050195061	1	1	0.987576770761023	0.987576770761023	1
up	CCL24; CCL21; CCL16; SIGLEC6; CXCL13; GREM1; AGT; POMC; C1QA; THY1; INHA; PGR; BMP3; GATA1; ADCYAP1; NTF3; SSTR3; VIPR2; GATA4; XCL1; FASLG; CCR5; CCL23; CCL18; CXCL6; TNFAIP6; GRAP; LILRB2; FGF14; FCRL2; TBX5; CCL13; BARX1; STAB1; IL36G; SIRPG; TNFSF18; CCL26; DRD2; PTH; DRD1; ADRA2A; FJX1;	GO:0007267~cell-cell signaling	43	230	18.695652173913	0.0404712826824759	0.972193431489622	1	1	0.99999999999995	0.99999999999995	1
down	FZD7; RGS11; EDN3; PDE6A; EDN2; AGTR1; GPR1; BDKRB1; NMU; AKR1C2; PDE1A; TAS1R3; ADGRF4; ADGRF2; NGEF; ARHGEF4; RGS17; GPR87; MRGPRX3; CCL22; GPR78; CCL17;	GO:0007186~G protein-coupled receptor signaling pathway	22	1152	1.90972222222222	0.0412777640120781	0.146409541132681	1	1	0.987576770761023	0.987576770761023	1
up	TYROBP; IL33; TREM2;	GO:0002282~microglial cell activation involved in immune response	3	4	75	0.0420721552528975	0.972193431489622	1	1	0.99999999999995	0.99999999999995	1
up	IL33; XCL1; IL1RL1;	GO:0002826~negative regulation of T-helper 1 type immune response	3	4	75	0.0420721552528975	0.972193431489622	1	1	0.99999999999995	0.99999999999995	1
up	PAX6; NKX6-1; NKX6-2;	GO:0021913~regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification	3	4	75	0.0420721552528975	0.972193431489622	1	1	0.99999999999995	0.99999999999995	1
up	MESP1; GATA5; ROBO2;	GO:0035481~positive regulation of Notch signaling pathway involved in heart induction	3	4	75	0.0420721552528975	0.972193431489622	1	1	0.99999999999995	0.99999999999995	1
up	OSM; LIFR; OSMR;	GO:0038165~oncostatin-M-mediated signaling pathway	3	4	75	0.0420721552528975	0.972193431489622	1	1	0.99999999999995	0.99999999999995	1
up	TAL1; SOX9; GCM1;	GO:0060018~astrocyte fate commitment	3	4	75	0.0420721552528975	0.972193431489622	1	1	0.99999999999995	0.99999999999995	1
up	FGF10; ALDH1A3; SOX9;	GO:0070384~Harderian gland development	3	4	75	0.0420721552528975	0.972193431489622	1	1	0.99999999999995	0.99999999999995	1
up	PLG; PLAT; NTRK2;	GO:0099183~trans-synaptic signaling by BDNF, modulating synaptic transmission	3	4	75	0.0420721552528975	0.972193431489622	1	1	0.99999999999995	0.99999999999995	1
down	ATG9B; TP53INP2; MAP1LC3A;	GO:0000045~autophagosome assembly	3	59	5.08474576271187	0.0427000702988403	0.146409541132681	1	1	0.987576770761023	0.987576770761023	1
down	DKK1; PTPRZ1; AMFR;	GO:0007611~learning or memory	3	59	5.08474576271187	0.0427000702988403	0.146409541132681	1	1	0.987576770761023	0.987576770761023	1
down	MT2A; PRKAA2; GPLD1;	GO:0035690~cellular response to drug	3	59	5.08474576271187	0.0427000702988403	0.146409541132681	1	1	0.987576770761023	0.987576770761023	1
up	FMO1; CYP2F1; CYP2C19; CYP2A7; CYP2A6; CYP2C9; CYP2G1P;	GO:0006082~organic acid metabolic process	7	21	33.3333333333333	0.044294106054193	0.972193431489622	1	1	0.99999999999995	0.99999999999995	1
up	CYP2C9; CYP2C19; CYP4A11; CYP2G1P; CYP2A7; CYP2F1; CYP2A6;	GO:0019373~epoxygenase P450 pathway	7	21	33.3333333333333	0.044294106054193	0.972193431489622	1	1	0.99999999999995	0.99999999999995	1
down	TF; FTH1; ABCB6;	GO:0006879~cellular iron ion homeostasis	3	60	5	0.0444326913315354	0.146409541132681	1	1	0.987576770761023	0.987576770761023	1
down	WNT4; ZHX3; CTNNBIP1;	GO:0045669~positive regulation of osteoblast differentiation	3	60	5	0.0444326913315354	0.146409541132681	1	1	0.987576770761023	0.987576770761023	1
down	AR; PTN; CDKN2B;	GO:0050680~negative regulation of epithelial cell proliferation	3	60	5	0.0444326913315354	0.146409541132681	1	1	0.987576770761023	0.987576770761023	1
down	IL1RN; ALDH3A1; HSD11B2;	GO:0051384~response to glucocorticoid	3	60	5	0.0444326913315354	0.146409541132681	1	1	0.987576770761023	0.987576770761023	1
down	UNC13B; TH; PRKAA2;	GO:0071333~cellular response to glucose stimulus	3	60	5	0.0444326913315354	0.146409541132681	1	1	0.987576770761023	0.987576770761023	1
up	APOA4; NR1H3; RGN; SLC45A3; APOA1;	GO:0045723~positive regulation of fatty acid biosynthetic process	5	12	41.6666666666667	0.0452417263764117	0.972193431489622	1	1	0.99999999999995	0.99999999999995	1
down	CRYAB; GRPEL2; ERO1A; AMFR; CLGN;	GO:0006457~protein folding	5	150	3.33333333333333	0.0458118960151972	0.146409541132681	1	1	0.987576770761023	0.987576770761023	1
down	CLGN; AKAP3; AR;	GO:0007338~single fertilization	3	61	4.91803278688525	0.0461998250756991	0.146409541132681	1	1	0.987576770761023	0.987576770761023	1
down	DKK1; ZNF365; RTN4RL1;	GO:0010977~negative regulation of neuron projection development	3	61	4.91803278688525	0.0461998250756991	0.146409541132681	1	1	0.987576770761023	0.987576770761023	1
up	IGFBP4; IGFBP3; IGFBP6; IGFBP5;	GO:0043567~regulation of insulin-like growth factor receptor signaling pathway	4	8	50	0.046997631703163	0.972193431489622	1	1	0.99999999999995	0.99999999999995	1
up	SELP; SELE; CCR2; FUT7;	GO:1903238~positive regulation of leukocyte tethering or rolling	4	8	50	0.046997631703163	0.972193431489622	1	1	0.99999999999995	0.99999999999995	1
down	SRPX2; SLITRK6; FLRT3;	GO:0051965~positive regulation of synapse assembly	3	62	4.83870967741935	0.0480012357782403	0.146409541132681	1	1	0.987576770761023	0.987576770761023	1
